Literature DB >> 24314688

Evoked potentials in multiple sclerosis.

George H Kraft1.   

Abstract

Before the development of magnetic resonance imaging (MRI), evoked potentials (EPs)-visual evoked potentials, somatosensory evoked potentials, and brain stem auditory evoked responses-were commonly used to determine a second site of disease in patients being evaluated for possible multiple sclerosis (MS). The identification of an area of the central nervous system showing abnormal conduction was used to supplement the abnormal signs identified on the physical examination-thus identifying the "multiple" in MS. This article is a brief overview of additional ways in which central nervous system (CNS) physiology-as measured by EPs-can still contribute value in the management of MS in the era of MRIs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain stem evoked responses; Evoked potentials; Somatosensory evoked potentials; Visual evoked potentials

Mesh:

Year:  2013        PMID: 24314688     DOI: 10.1016/j.pmr.2013.07.001

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  3 in total

1.  Auditory Brainstem Response Wave Amplitude Characteristics as a Diagnostic Tool in Children with Speech Delay with Unknown Causes.

Authors:  Susan Abadi; Ghamartaj Khanbabaee; Kourosh Sheibani
Journal:  Iran J Med Sci       Date:  2016-09

2.  Somatosensory evoked potentials and their relation to microstructural damage in patients with multiple sclerosis-A whole brain DTI study.

Authors:  Jan Hamann; Barbara Ettrich; Karl Titus Hoffman; Florian Then Bergh; Donald Lobsien
Journal:  Front Neurol       Date:  2022-08-29       Impact factor: 4.086

3.  Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity.

Authors:  Lucas Schirmer; Wiebke Möbius; Chao Zhao; Andrés Cruz-Herranz; Lucile Ben Haim; Christian Cordano; Lawrence R Shiow; Kevin W Kelley; Boguslawa Sadowski; Garrett Timmons; Anne-Katrin Pröbstel; Jackie N Wright; Jung Hyung Sin; Michael Devereux; Daniel E Morrison; Sandra M Chang; Khalida Sabeur; Ari J Green; Klaus-Armin Nave; Robin Jm Franklin; David H Rowitch
Journal:  Elife       Date:  2018-09-11       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.